Morningstar Investor users sign in here.

Company Profile

  • Business description

    Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

  • Contact

    7946 Ivanhoe Avenue
    Suite 201
    La Jolla CA 92037
    USA

    T: +1 858 263-4196

    https://www.ensysce.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    8

Stocks News & Analysis

stocks

What can the Guzman burrito hype teach us about investing?

At a certain point common sense has to prevail with any investment.
stocks

Undervalued ASX share proposes merger

We view the proposed tie up as value-dilutive but the shares remain undervalued. 
stocks

7 ASX and global picks for an income growth portfolio

An income portfolio should include both high yields and the potential for dividend growth. I’ve outlined 7 opportunities for investors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,039.90 27.80 0.35%
CAC 40 7,628.57 42.77 -0.56%
DAX 40 18,163.52 90.66 -0.50%
Dow JONES (US) 39,150.33 15.57 0.04%
FTSE 100 8,237.72 34.74 -0.42%
HKSE 18,028.52 306.80 -1.67%
NASDAQ 17,689.36 32.23 -0.18%
Nikkei 225 38,596.47 36.55 -0.09%
NZX 50 Index 11,682.39 89.42 -0.76%
S&P 500 5,464.62 8.55 -0.16%
S&P/ASX 200 7,796.00 26.60 0.34%
SSE Composite Index 2,998.14 7.30 -0.24%

Market Movers

Name
Last price
Change
% Change
Red 5 Ltd RED 0.42 0.01 2.44%
Bellevue Gold Ltd BGL 1.81 0.05 -2.70%
Pilbara Minerals Ltd PLS 3.11 0.09 -2.81%
Nickel Industries Ltd NIC 0.83 0.03 -3.51%
South32 Ltd S32 3.72 0.02 0.54%
Core Lithium Ltd CXO 0.08 0.01 -8.79%
Telstra Group Ltd TLS 3.66 0.05 1.39%
Liontown Resources Ltd LTR 0.94 0.05 -5.08%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Botanix Pharmaceuticals Ltd BOT 0.36 0.03 7.46%